Activating Transcription Factor 4 Mediates Adaptation of Human Glioblastoma Cells to Hypoxia and Temozolomide

Researchers hypothesized that activating transcription factor 4 was essential for the adaptation of human glioblastoma cells to the conditions of the tumor microenvironment and contributed to therapy resistance against chemotherapy.